statistiche ricercatore

Continente	#
NA - Nord America	760
AS - Asia	540
EU - Europa	360
SA - Sud America	57
Continente sconosciuto - Info sul continente non disponibili	29
AF - Africa	23
Totale	1.769

Nazione	#
US - Stati Uniti d'America	749
CN - Cina	139
VN - Vietnam	136
SG - Singapore	133
GB - Regno Unito	106
DE - Germania	55
HK - Hong Kong	49
SE - Svezia	45
BR - Brasile	42
FR - Francia	36
IT - Italia	36
IN - India	26
RU - Federazione Russa	24
IE - Irlanda	18
JO - Giordania	12
JP - Giappone	11
EE - Estonia	9
UA - Ucraina	9
ZA - Sudafrica	9
PH - Filippine	8
CI - Costa d'Avorio	7
NL - Olanda	7
AR - Argentina	6
BD - Bangladesh	5
BG - Bulgaria	5
CA - Canada	4
TR - Turchia	4
CL - Cile	3
IQ - Iraq	3
TG - Togo	3
DO - Repubblica Dominicana	2
EC - Ecuador	2
FI - Finlandia	2
ID - Indonesia	2
IR - Iran	2
PK - Pakistan	2
PL - Polonia	2
PY - Paraguay	2
SA - Arabia Saudita	2
TH - Thailandia	2
AE - Emirati Arabi Uniti	1
AT - Austria	1
BB - Barbados	1
BE - Belgio	1
BS - Bahamas	1
CH - Svizzera	1
CO - Colombia	1
CU - Cuba	1
DK - Danimarca	1
EG - Egitto	1
ES - Italia	1
KR - Corea	1
MA - Marocco	1
MU - Mauritius	1
MX - Messico	1
PE - Perù	1
SK - Slovacchia (Repubblica Slovacca)	1
SV - El Salvador	1
TW - Taiwan	1
UZ - Uzbekistan	1
ZM - Zambia	1
Totale	1.740

Nome	#
Identification of the NUP98-PHF23 fusion gene in pediatric cytogenetically normal acute myeloid leukemia by whole-transcriptome sequencing	225
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis	197
LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia	180
Minimal residual disease monitored after induction therapy by rq-pcr can contribute to tailor treatment of patients with t(8;21) runx1-runx1t1 rearrangement	174
Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial	164
Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia: A report from the italian AIEOP study group	156
Prognostic significance of flow-cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP-AML 2002/01 study protocol	154
MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatment	142
Targeting BAG-1: A novel strategy to increase drug efficacy in acute myeloid leukemia	141
CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells	123
Targeting metabolic vulnerabilities and aberrant signal transduction pathways in paediatric T-cell Acute Lymphoblastic Leukaemia (T-ALL)	113
Totale	1.769

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	154	0	0	9	15	25	8	3	15	11	4	29	35
2022/2023	184	17	24	7	20	6	10	10	6	44	6	28	6
2023/2024	30	2	6	5	2	3	7	2	1	0	2	0	0
2024/2025	261	9	38	8	13	72	7	9	14	1	27	1	62
2025/2026	517	19	35	44	56	49	19	37	51	145	44	8	10
2026/2027	34	11	23	0	0	0	0	0	0	0	0	0	0
Totale													1.769

CRIS Current Research Information System